The Patent Finder
KU

Keio University

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

141 patents currently held

72 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2 more records may belong here and await a decision; they are not counted.

The next term ends in Mar 2027. from the record

Of the 72 now held by other companies, 17 name Thruchip Japan Inc. as their current owner, and 55 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
6
Ending by 2030
Mar 2027
Next term end
121
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Directional Coupling Communication Apparatus US 10,291,290
The most cited patent in this portfolio, cited by 109 later US patents, top 5% of utility patents granted in 2019 in our data. Protection runs to 2033.
Ends Nov 2033 · High confidence
Also notable
Compositions and Methods for the Induction of CD8+ T-Cells US 10,695,412
Cited by 9 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2037. A terminal disclaimer caps this term to an earlier patent's.
Ends Dec 2037 · High confidence
Also notable
Method For Differentiating Pluripotent Stem Cells Into Desired Cell Type US 10,836,997
Cited by 10 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2037.
Ends Aug 2037 · High confidence

Formerly held, still cited

Notable
Cited by 61 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2030.
now held by Toyobo Co., Ltd.
Ends May 2030 · High confidence
Also notable
Cited by 10 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2037.
Ends Dec 2037 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 3 fees due Dec 4 to 25, 2026 · next Dec 4
  • 2 fees due Jan 9 to 11, 2027 · next Jan 9
  • 5 fees due Feb 1 to 28, 2027 · next Feb 1
  • 2 fees due Mar 19 to 24, 2027 · next Mar 19
  • 2 fees due May 19 to 26, 2027 · next May 19
  • 7 fees due Jun 5 to 29, 2027 · next Jun 5
  • 4 fees due Jul 2 to 16, 2027 · next Jul 2
  • 5 fees due Aug 4 to 18, 2027 · next Aug 4
  • 3 fees due Sep 3 to 15, 2027 · next Sep 3
  • 2 fees due Oct 9 to 16, 2027 · next Oct 9
  • 2 fees due Nov 5, 2027

Which patents, and when each one lapses · Pro

Recent changes

  • 8 of the patents on this record were granted since Aug 23, 2026
  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 8,518,880Therapeutic Agent for Spinal Cord Injuries
In force
 · High confidence
In forceHigh confidence
US 7,964,177Method for Determination of Oxidative Stress
In force
 · High confidence
In forceHigh confidence
US 7,915,802Surface Light Emitting Device and Polarization Light Source
In force
 · High confidence
In forceHigh confidence
US 8,592,643Methods for Introducing a Human Gene into a Marmoset Embryo for Making a Transgenic Marmoset
In force
 · High confidence
In forceHigh confidence
US 8,841,250A Method for Promoting Muscle Repair Comprising Administering G-Csf at the Site of Injury
In force
 · Medium confidence
In forceMedium confidence
US 8,877,222Antibacterial Medical Equipment and Method for Producing the Same
In force
 · High confidence
In forceHigh confidence
US 9,029,513Anti-Egfr Antibody and Use Thereof
In force
 · High confidence
In forceHigh confidence
US 8,895,997Carbon Nanotube Light Emitting Device, Light Source, and Photo Coupler
In force
 · High confidence
In forceHigh confidence
US 9,419,684Inter-Module Communication Apparatus
In force
 · High confidence
In forceHigh confidence
US 10,309,957A Method for Determining Sensitivity to Fluorouracil in a Subject Having Colorectal Cancer
In force
 · High confidence
In forceHigh confidence
10 of 141 patents shown.
Pro members see all 141.
Pro members: see all 141 patents
Also on record, not counted in the 141: 72 patents in force now held by others · 166 patents ended · 156 applications pending · 226 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited